QIPT
Quipt Home Medical Corp.
Set alert
- YTD
- +3.40%
- 1 year
- +54.01%
- Open
- 3.65
- Prev close
- 3.65
- Mkt cap
- 103.85M
- Vol
- 1.36M
- Avg vol
- 157.60K
- EPS
- -0.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.65
- High
- 3.65
- Forward P/E
- -40.17
- Beta
- 1.03
- Short ratio
- 6.30
- Inst. own
- 55.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 2.69
- 200-d avg
- 3.22
- 1y target
- 8.00
Key statistics
- Market cap
- 103.85M
- Enterprise value
- 216.07M
- Trailing P/E
- 0.00
- Forward P/E
- -40.17
- PEG ratio
- 0.00
- Price / sales
- 0.43
- Price / book
- 0.95
- EPS (TTM)
- -0.16
- Beta
- 1.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -2.04%
- Revenue (TTM)
- 244.23M
- Revenue growth
- 5.00%
- Free cash flow
- 35.74M
- Total cash
- 14.40M
- Total debt
- 98.19M
- Return on equity
- -4.51%
- Shares outstanding
- 43.09M
- Short % of float
- 0.00%
- 50-day average
- 2.69
- 200-day average
- 3.22
Analyst view
Consensus: strong buy
- Target (low)
- 4.00
- Target (mean)
- 8.00
- Target (high)
- 12.00
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Dec 16, 2024 | Sep 1, 2024 | 0.01 | -0.07 | -0.08 | -800.00% |
| Aug 14, 2024 | Jun 1, 2024 | 0.01 | -0.04 | -0.05 | -500.00% |
| Aug 14, 2024 | Jun 1, 2024 | 0.01 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.01 | -0.03 | -0.04 | -400.00% |
| May 15, 2024 | Mar 1, 2024 | 0.01 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2024 | Benchmark | main | Buy | Buy |
| Aug 16, 2024 | Canaccord Genuity | main | Buy | Buy |
| May 20, 2024 | Benchmark | main | Buy | Buy |
| May 17, 2024 | Canaccord Genuity | main | Buy | Buy |
About Quipt Home Medical Corp.
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- quipthomemedical.com
News
- Head to Head Comparison: QuidelOrtho (NASDAQ:QDEL) vs. Quipt Home Medical (NASDAQ:QIPT)
- Quipt Home Medical Receives Final Order Approving Arrangement
- Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders
- Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement
- Shareholder Alert: The Ademi Firm investigates whether Quipt Home Medical Corp. is obtaining a Fair Price for its Public Shareholders
- Quipt Home Medical Target of Unusually Large Options Trading (NASDAQ:QIPT)
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Quipt Home Medical Corp. (NASDAQ: QIPT)
- 12 Health Care Stocks Moving In Monday's Intraday Session
- QIPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Quipt Home Medical Corp. is Fair to Shareholders
- Concerned Shareholder Bradley L. Radoff Urges Quipt Home Medical's Board of Directors to Pursue a Value-Maximizing Sale
Your note
Sign in to keep a note on QIPT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Carter (Kevin) | Director of Issuer | Acquisition or disposition in the public market | Sep 1, 2021 | 4,995 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Claret Asset Management Corp | 10.55% | 4,548,213 | 10.96M | Sep 29, 2024 |
| Forager Capital Management, LLC | 9.73% | 4,192,562 | 10.10M | Sep 29, 2024 |
| Blackrock Inc. | 4.69% | 2,019,319 | 4.87M | Sep 29, 2024 |
| Royce & Associates LP | 4.10% | 1,768,789 | 4.26M | Sep 29, 2024 |
| First Manhattan Co. LLC | 3.71% | 1,600,000 | 3.86M | Sep 29, 2024 |
| Kennedy Capital Management, Inc. | 2.22% | 954,736 | 2.30M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royce Small-Cap Opportunity Fund | 2.40% | 1,033,126 | 2.49M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.23% | 959,503 | 2.31M | Oct 30, 2024 |
| Putnam Small Cap Value Fund | 1.21% | 519,400 | 1.25M | Aug 30, 2024 |
| Fidelity Small Cap Index Fund | 0.97% | 417,124 | 1.01M | Aug 30, 2024 |
| iShares Russell 2000 Value ETF | 0.67% | 289,971 | 698.83K | Oct 30, 2024 |
| Russell Inv Co-U.S. Small Cap Equity Fund | 0.61% | 263,485 | 635.00K | Jul 30, 2024 |